TB-500 (Thymosin β4 fragment)

TB-500 Benefits: What Is Established and What Is Not

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-313 cited sources

The short answer

Reported effects span actin sequestration, cell migration, angiogenesis, corneal wound healing and cardiac repair models. Actin sequestration is the best established and the most attributable to the fragment; the repair literature is more extensive and largely used full-length thymosin beta-4.

Key facts

Best established
G-actin sequestration
Well supported
Cell migration in vitro
Reported
Angiogenesis, corneal and cardiac repair
Dominant evidence type
In vitro and animal models
Compound in repair work
Largely full-length Tβ4
Human clinical data
Limited

Sorted by how well established

Actin sequestration is the firmest: it is the protein's recognised molecular function, mechanistically characterised, and the fragment carries the motif associated with it. Cell migration follows, with a short mechanistic route from actin and consistent in vitro results. Angiogenesis and tissue repair are more distant. These are real reported findings, but with longer causal chains and more dependence on the specific model.

The corneal work

Sosne and colleagues reported in Experimental Eye Research in 2002 that thymosin beta-4 promotes corneal wound healing and decreases inflammation in an animal model. The cornea is a useful system for wound work (accessible, avascular, and easy to image), and this is among the more frequently cited findings in the field. It used the protein.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

The cardiac work

Shrivastava and colleagues reviewed thymosin beta-4 and cardiac repair in the Annals of the New York Academy of Sciences in 2010. Cardiac repair attracted substantial interest because the heart regenerates poorly, making any candidate promoting repair notable. Again, the protein.

The pattern worth noticing

The findings that make TB-500 interesting commercially (wound healing, tissue repair, cardiac regeneration) are largely findings about thymosin beta-4. The findings most attributable to TB-500 itself are the molecular ones. That inversion is the single most useful thing to hold in mind when reading marketing material about this compound.

What is absent

Substantial human clinical data. Registered interventional trials of the heptapeptide. Independent confirmation that the fragment reproduces the protein's repair effects. None of these absences refutes anything; together they mark where the evidence stops.

Frequently asked questions

What is TB-500 best established for?

Actin sequestration: the recognised molecular function of its parent protein, and the activity the fragment's motif carries.

Is the wound-healing evidence about TB-500?

Largely about full-length thymosin beta-4. The distinction is routinely lost in secondary writing.

Is there human clinical evidence?

Limited. The literature is predominantly in vitro and animal work.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.